Background illustration for clinical trials search

Paid Clinical Trials Ohio

Discover 3,048 paid clinical trials in Ohio. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting

Pirfenidone for Progressive Fibrotic Sarcoidosis

for
Sarcoidosis, Pulmonary
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18 - 70+

Code: NCT03260556

Recruiting

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

for
Allogeneic Hematopoietic Cell Transplantation
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT05501756

Phase2, Recruiting

Exciflex Electroceutical Banadage for Chronic Wound Therapy

for
Chronic Wound, Diabetes, Spinal Cord Injury, Ischemic Wound
Location: Cleveland OH
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT04887688

Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Bridgeport CT, The Bronx NY, New York NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: New York NY, Philadelphia PA, Durham NC, Miami FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase1, Recruiting

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

for
Gastrointestinal Cancer, Colon Cancer, Rectal Cancer,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06263088

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase1, Recruiting

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Durham NC, Columbus OH, Ann Arbor MI, Duarte CA
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT04858256

Phase2, Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

for
Hypogammaglobulinemia, Bacterial Infections,
Location: Greenville NC, Bethesda MD, Morrisville NC,
Sponsor: Grifols Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05645107

Phase3, Recruiting

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

for
Sickle Cell Disease
Location: New York NY, Washington D.C. DC, Toronto, Charlotte NC,
Sponsor: Robert Nickel

Sex: All

Age: 2 - 25

Code: NCT03587272

Phase2, Recruiting

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

for
Cancer of the Prostate, Castration-resistant Prostate Cancer
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: Male

Age: 18+

Code: NCT03960788

Early_phase1, Recruiting

Study of ALTO-300 in MDD

for
Major Depressive Disorder
Location: Norwalk CT, Staten Island NY, Media PA, Allentown PA,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase2, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for
Breast Cancer, HER2-positive Breast Cancer
Location: Brewer ME, Scarborough ME, Weymouth MA, Danvers MA,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04893109

Phase2, Recruiting

Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion

for
Spinal Fusion
Location: Akron OH
Sponsor: Akron Children's Hospital

Sex: All

Age: 0 - 26

Code: NCT06744907

Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Primary Myelofibrosis, Post-PV MF,
Location: Canton OH, Cincinnati OH, Birmingham AL, Houston TX
Sponsor: Telios Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05280509

Phase1, Phase2, Recruiting

Trial-Ready Cohort-Down Syndrome (TRC-DS)

for
Down Syndrome, Alzheimer Disease, Dementia
Location: Boston MA, Staten Island NY, Pittsburgh PA,
Sponsor: University of Southern California

Sex: All

Age: 25 - 55

Code: NCT04165109

Recruiting

Safer Still (Exploratory Project 3)

for
Suicide Prevention
Location: Columbus OH
Sponsor: Jeff Bridge

Sex: All

Age: 18 - 70+

Code: NCT06558409

Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: Mineola NY, New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06400472

Phase1, Recruiting

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Ohio offers distinct advantages in the clinical research landscape. The state's diverse population provides a wide range of participants, enhancing the accuracy and relevance of research outcomes. Ohio is also recognized for its strong research environment, with a focus on medical innovation and pioneering studies in various fields.

By choosing to participate in a clinical trial in Ohio, participants contribute to vital medical research while benefiting from a well-established clinical trial infrastructure supported by top-tier healthcare institutions. This ensures they receive cutting-edge care and support throughout the process.

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio